Gradient Investments LLC Tg Therapeutics, Inc. Transaction History

Gradient Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$8.36 - $26.5 $2,591 - $8,215	-310 Reduced 99.36%	2 $0
Q2 2023 Jul 11, 2023	SELL	$15.48 - $35.0 $2,414 - $5,460	-156 Reduced 33.33%	312 $7,000
Q2 2022 Jul 11, 2022	BUY	$3.74 - $10.66 $590 - $1,684	158 Added 50.97%	468 $2,000
Q1 2022 May 26, 2022	BUY	$7.81 - $20.45 $390 - $1,022	50 Added 19.23%	310 $3,000
Q3 2021 Oct 18, 2021	BUY	$21.78 - $40.45 $5,662 - $10,517	260 New	260 $9,000

396

90.6M

1.77M

1.9M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.5B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.